Centers for Medicare & Medicaid Services

Coverage with Evidence Development

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease (AD)
Posted new study.
https://www.cms.gov/medicare/coverage-evidence-development/monoclonal-antibodies-directed-against-amyloid-treatment-alzheimers-disease-ad

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud 7500 Security Boulevard Baltimore MD 21244